Nancy Klemm

Nancy Klemm

Auto-generated profile, based on publicly available information

Nancy Klemm

Department of Medical Oncology and Hematology, University of Zurich and University Hospital Zurich, Zurich, Switzerland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2025 in Cancer Research
Verified
Journal Article
Open access
NKNancy Klemm
Nancy Klemm
RSRoman R. Schimmer
Roman R. Schimmer
NKNils K. Konrad
Nils K. Konrad
FTFlavian Thelen
Flavian Thelen
JFJonas Fullin
Jonas Fullin
SBSteffen Boettcher
Steffen Boettcher
Missense mutants of p53, such as the frequent hotspot variant R248Q, exert a dominant-negative effect (DNE) on wild-type (WT) p53 in cancer cells with monoallelic TP53 mutations. However, the precise functional and molecular mechanisms of the DNE have remained elusive due to a lack of appropriate model systems. In this study, we developed a variety of model systems, including CRISPR-edited human isogenic cell lines and transcriptional reporter cell lines, and targeted protein degradation assays that were combined with functional and molecular analyses to functionally characterize the DNE. Formation of heterotetramers between R248Q and WT p53 impaired proper WT p53 functionality by preventing DNA binding and subsequent target gene transactivation. Furthermore, the markedly increased protein half-life of R248Q led to supraphysiologic levels of R248Q, which was critically required for the DNE. Drug-induced targeted protein degradation of R248Q to lower the R248Q:WT ratio restored the transcriptional activity of WT p53, induced antiproliferative effects in cancer cells in vitro, and elicited strong therapeutic activity in vivo. Together, this study provides mechanistic insights into the DNE of p53 missense mutants and indicates that the DNE represents a promising therapeutic target. Significance: Heterotetramerization between R248Q mutant and wild-type p53 in conjunction with supraphysiologic p53R248Q accumulation underlies the dominant-negative effect, highlighting the need to develop pharmacologic strategies to decrease the elevated R248Q:WT ratio. See related commentary by Gencel-Augusto and Lozano, p. 1955

2 June 2025
Verified
Other
Open access
NKNancy Klemm
Nancy Klemm
RSRoman R. Schimmer
Roman R. Schimmer
NKNils K. Konrad
Nils K. Konrad
FTFlavian Thelen
Flavian Thelen
JFJonas Fullin
Jonas Fullin
SBSteffen Boettcher
Steffen Boettcher
Figure S2 showing immunofluorescence images comparing the p53 levels in +/+, +/-, -/-, R248Q/+ and R248Q/- cells when treated with DMSO.

2 June 2025
Verified
Other
Open access
NKNancy Klemm
Nancy Klemm
RSRoman R. Schimmer
Roman R. Schimmer
NKNils K. Konrad
Nils K. Konrad
FTFlavian Thelen
Flavian Thelen
JFJonas Fullin
Jonas Fullin
SBSteffen Boettcher
Steffen Boettcher
Figure S4A illustrating that heterotetramerization is required for the DNE in vivo when xenografting MOLM13-TP53 WT cells overexpressing either tetramerization-proficient (R248Q) and tetramerization-deficient (R248Q-L344P) in NSG mice and treated with Idasanutlin. Figure S4B showing FACS data of how electroporation of plasmids encoding WT p53 into cells with endogenous TP53R248Q (K562-TP53R248Q-p21-GFP) almost fully restored the p21-GFP reporter signal.

2 June 2025
Verified
Other
Open access
NKNancy Klemm
Nancy Klemm
RSRoman R. Schimmer
Roman R. Schimmer
NKNils K. Konrad
Nils K. Konrad
FTFlavian Thelen
Flavian Thelen
JFJonas Fullin
Jonas Fullin
SBSteffen Boettcher
Steffen Boettcher
Figure S1 showing NSG mice engrafted with MOLM13-TP53 isogenic AML cells carrying -/-, R248Q/+, or R248Q/- alleles with resistance to Idasanutlin, increased leukemic burden, which rapidly succumbed to the disease, whereas mice xenografted with cells with +/+ or +/- alleles had reduced leukemic burden and significantly prolonged survival

2 June 2025
Verified
Other
Open access
NKNancy Klemm
Nancy Klemm
RSRoman R. Schimmer
Roman R. Schimmer
NKNils K. Konrad
Nils K. Konrad
FTFlavian Thelen
Flavian Thelen
JFJonas Fullin
Jonas Fullin
SBSteffen Boettcher
Steffen Boettcher
Figure S5A-B showing degradation of GFP and R248Q-GFP fusion protein via ratio of GFP vs. mCherry induced by three different molecular glues, namely Lenalidomide, Pomalidomide and Iberdomide precisely calculated on single-cell basis via flow cytometric analysis

2 June 2025
Verified
Other
Open access
NKNancy Klemm
Nancy Klemm
RSRoman R. Schimmer
Roman R. Schimmer
NKNils K. Konrad
Nils K. Konrad
FTFlavian Thelen
Flavian Thelen
JFJonas Fullin
Jonas Fullin
SBSteffen Boettcher
Steffen Boettcher
Figure S3A showing results of FRET assays to demonstrate oligomerization of R248Q and WT. Figure S3B-C underlining the dimer-of dimer topology as tetramers are largely formed upon dimerization of homodimers. Figure 3D-E demonstrating that WT p53 functionality depends on oligomerization and further, that the dependency of the DNE relies on the oligomerization capability of R248Q.